Supraceliac aortic occlusion: a safe approach to pararenal aortic aneurysms.
Twenty-four patients who underwent surgery for pararenal aortic aneurysms between January 1992 and April 1997 are reviewed. Eighteen patients had primary atherosclerotic aneurysms, three patients had symptomatic infected aneurysms, two patients had an aneurysm proximal to a prior aortic repair, and one patient had a pseudoaneurysm of a proximal aortic graft anastomosis. Thirteen patients underwent elective operation, five had an urgent operation, and six patients underwent an emergency procedure. Five patients had the proximal aortic clamp placed between the renal arteries (Group I), three patients had it placed between the superior mesenteric and the renal arteries (Group II), and 16 patients had it placed in a supraceliac location (Group III). Aneurysm size, age, sex, preoperative blood chemistries (including hemoglobin, hematocrit, liver function studies, and coagulation studies) were similar in all groups. Two patients in Group III were on hemodialysis preoperatively. Preoperative renal function (blood urea nitrogen and creatinine) was the same in all groups. Visceral ischemic time was 43.4 +/- 9.37 min to the distal kidney in Group I, 26.6 +/- 7.63 min in Group II, and 24.5 +/- 6.22 min in Group III. Mean transfusion requirements were similar in all groups. Two patients in Group I required postoperative hemodialysis. No patient in either Group II or III developed renal insufficiency. Mortality was the same in each group but was related to the urgency of operation (elective 7.6%, urgent 40%, emergent 50%). Intrarenal clamping (Group I) was associated with more renal and gastrointestinal complications than either suprarenal or supraceliac clamping. Although suprarenal and supraceliac clamping had similar results, our preference is supraceliac clamping because it is technically easy to achieve and is associated with few end-organ complications.
Hines
G L
GL
Division of Vascular Surgery, Winthrop-University Hospital, Mineola, New York 11501, USA.
Chorost
M
M
D000368:Aged; D017541:Aneurysm, False / Q000401:mortality / Q000601:surgery; D000785:Aneurysm, Infected / Q000401:mortality / Q000601:surgery; D017544:Aortic Aneurysm, Abdominal / Q000401:mortality / Q000601:surgery*; D001161:Arteriosclerosis / Q000401:mortality / Q000601:surgery; D002445:Celiac Artery / Q000601:surgery*; D004630:Emergencies; D005260:Female; D006083:Graft Occlusion, Vascular / Q000401:mortality / Q000601:surgery; D006801:Humans; D007511:Ischemia / Q000209:etiology* / Q000401:mortality; D007668:Kidney / Q000098:blood supply*; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000401:mortality; D007677:Kidney Function Tests; D008297:Male; D017538:Mesenteric Artery, Superior / Q000601:surgery; D008875:Middle Aged; D011183:Postoperative Complications / Q000209:etiology / Q000401:mortality / Q000601:surgery*; D012008:Recurrence; D012077:Renal Artery / Q000601:surgery; D012086:Reoperation; D015996:Survival Rate; D016896:Treatment Outcome